From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Össur hf.
Traded asNasdaq CopenhagenOSSR
IndustryHealth care
Area served
Key people
Jon Sigurdsson
(President and CEO)

Niels Jacobsen
Sveinn Solvason
ProductsNon-invasive orthopaedic bracing and support, compression therapy, prosthetics
RevenueIncrease US $436 million (2013)[1]
Increase US $75.5 million (2013)[1]
Increase US $41 million (2013)[1]
Total assetsIncrease US $706.2 million (2013)[1]
Total equityIncrease US $448 million (2013)[1]
Number of employees
3000 (average, 2018)[2]

Össur hf. is an Icelandic company that develops, manufactures and sells non-invasive orthopaedics equipment, including bracing and support products, compression therapy, and prosthetics. The company's headquarters is in Reykjavík, and it has offices in the Americas, Europe, and Asia, with distributors in other markets.


Össur was founded in Iceland in 1971 by Össur Kristinsson, a prosthetist. His family owned the company until 1999, when it went public and was listed on the Iceland Stock Exchange. Initially, the company served only the domestic Icelandic market, and then began to export in 1986. It currently employs around 2,300 staff in 18 locations.[citation needed]

In 2006, the company was named as a "technology pioneer" by the World Economic Forum.[3]


Since 2000, Össur has acquired 16 companies. The Gibaud Group operates autonomously.

  • 2000 – Skóstofan [4]
  • 2000 – Flex-Foot, Inc.
  • 2000 – PI Medical AB.[5]
  • 2000 – Karlsson & Bergstrom AB.[5]
  • 2000 – Century XXII Innovations, Inc
  • 2003 – Linea Orthopedics AB.
  • 2003 – Generation II Group, Inc.[6]
  • 2005 – Advanced Prosthetic Components
  • 2005 – Royce Medical, Inc.
  • 2005 – Innovative Medical Products, Ltd.
  • 2005 – GBM Medical AB.
  • 2006 – Innovation Sports, Inc.
  • 2006 – Gibaud Group[7]
  • 2007 – SOMAS
  • 2010 – Orthopaedic Partner Africa [8]
  • 2012 – Evolution Industries
  • 2016 – Touch Bionics
  • 2017 – Medi Prosthetics


Research and development[edit]

Össur operates five research and development (R&D) departments in four countries, employing 76 people. In-house R&D also partners with third parties, including universities and research companies[which?]. In 2007, R&D investment amounted to 6 percent of the company’s total sales[citation needed]. The same year, 22 US patents were granted to Össur and 37 new applications filed[citation needed]. At the end of the year, Össur had 218 US, 26 European, and 103 granted international patents in its portfolio, together with 119 US and 239 pending applications world.[citation needed]


The company operates in three markets: bracing & support, compression therapy, and prosthetics including bionics technology. It manufactures a range of braces and support products for arms, legs, and torso. Products include Unloader One, a brace that provides mechanical support to reduce the knee pain caused by osteoarthritis. It's designed to separate bones when ligaments and cartilage are damaged, and to prevent further damage to the joint. The firm also makes the CTi (formerly sold as the CTi2), a ligament brace for knees used for both rehabilitation and for injury prevention, as well as cervical collars.

Össur entered the compression therapy segment with the acquisition of the French company Gibaud. Products include bandages, tights, stockings, knee highs and stump socks.


Össur manufactures prosthetic limbs and joints, liners, sockets, locks and sleeves. Its products include Flex-Foot, a prosthetic foot made from carbon fiber, a material used in the aerospace industry for its strength and flexibility. The Flex-Foot Cheetah developed by medical engineer Van Phillips and worn by Alan Oliveira and other amputee athletes is a derivative of this product line.[citation needed] Össur also produces the Total Knee prosthetic, which possesses a "locking moment" which keeps the knee from collapsing when it is in full extension, Mauch Knee, which has a hydraulic system for fluid and natural gait, and Iceross silicone prosthetic liners, which provide an interface between the skin and the socket.[citation needed]

The company's bionic technology platform is designed to restore anatomical function displaced by amputation by using intelligent structures in products that can respond in a human-like way. The division's products are Rheo Knee, a microprocessor swing and stance knee system which utilizes artificial intelligence, Power Knee, which works as an integrated extension of its user, synchronizing motion with that of the sound leg using motor power, and Proprio Foot, an intelligent and motor-powered foot module.[citation needed]

Össur has been developing a bionic limb controlled using implanted myoelectric sensors developed by the Alfred Mann Foundation.[9] One patient has used the limb for over a year, and reports a positive experience. Ossur says that the implantable control sensors will be a technology upgrade for its prosthetics in three to five years.


The firm's "Team Össur" comprises international athletes and performers and professionals who use Össur prosthetics. Under this program, Össur is a major sponsor of disabled athletes, including Paralympians and world record holders Sarah Reinertsen, Jody Cundy and Rudy Garcia-Tolson. The company has also sponsored Paralympian runner Brian Frasure, now a certified prosthetist and mentor to Oscar Pistorius, and Mike McNaughton, a Staff Sergeant in the Louisiana Army National Guard who lost his leg to a land mine in Afghanistan and was subsequently awarded a Bronze Star and a Purple Heart.


  1. ^ a b c d e "Annual Report 2013". Össur. Retrieved 31 December 2013.
  2. ^ "About Ossur". Ossur. Retrieved November 1, 2013.
  3. ^ "The New Edge of Technology". World Economic Forum.
  4. ^ "Össur hf. kaupir Skóstofuna".
  5. ^ a b Flex-Foot Parent Buys Two Swedish ProstheticFirms.
  6. ^ Ossur Reorganizes in US
  7. ^ "Össur hf. acquires the Gibaud Group in France". 22 December 2006.
  8. ^ "Össur expands global network with new base in South Africa".
  9. ^ "Amputees control bionic legs with their thoughts". Reuters. 20 May 2015.

External links[edit]